Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Tonggan Medical Technology is a Chinese biotechnology company specializing in the development of integrated microfluidic molecular diagnostic systems. Based in Wuhan's Optics Valley, the company focuses on "sample-in, result-out" automated platforms that streamline complex genetic testing for clinical and point-of-care applications. Their core product line includes the TG-1000 series of automated nucleic acid analyzers and a suite of diagnostic reagents targeting infectious diseases, oncology, and maternal-child health. By integrating sample preparation and detection into a single closed system, Tonggan Medical reduces the risk of contamination and the need for specialized laboratory infrastructure. The company serves hospitals, CDC centers, and primary healthcare providers across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Tonggan Medical Technology.